Analysts at Buckingham Didn’t Change their “Buy” rating for TJX Companies (TJX). The PT Given is $82; Shorts at Marrone Bio Innovations (MBII) Raised By 4.08%

November 15, 2017 - By Clifton Ray

Marrone Bio Innovations Incorporated (NASDAQ:MBII) had an increase of 4.08% in short interest. MBII’s SI was 1.55M shares in November as released by FINRA. Its up 4.08% from 1.49 million shares previously. With 106,400 avg volume, 15 days are for Marrone Bio Innovations Incorporated (NASDAQ:MBII)’s short sellers to cover MBII’s short positions. The SI to Marrone Bio Innovations Incorporated’s float is 7.85%. About 300 shares traded. Marrone Bio Innovations Inc (NASDAQ:MBII) has risen 94.03% since November 15, 2016 and is uptrending. It has outperformed by 77.33% the S&P500.

Among 26 analysts covering The TJX Companies (NYSE:TJX), 23 have Buy rating, 0 Sell and 3 Hold. Therefore 88% are positive. The TJX Companies has $92 highest and $7200 lowest target. $83.16’s average target is 23.20% above currents $67.5 stock price. The TJX Companies had 57 analyst reports since August 10, 2015 according to SRatingsIntel. Credit Suisse maintained the shares of TJX in report on Wednesday, August 2 with “Hold” rating. The firm has “Outperform” rating by Wedbush given on Wednesday, August 17. The stock of TJX Companies Inc (NYSE:TJX) earned “Buy” rating by RBC Capital Markets on Monday, September 18. BB&T Capital initiated the stock with “Buy” rating in Thursday, December 17 report. On Thursday, June 8 the stock rating was maintained by BMO Capital Markets with “Buy”. Telsey Advisory Group maintained it with “Market Perform” rating and $82 target in Wednesday, August 19 report. As per Tuesday, September 26, the company rating was maintained by BMO Capital Markets. S&P Research maintained the shares of TJX in report on Wednesday, August 19 with “Buy” rating. The stock of TJX Companies Inc (NYSE:TJX) has “Outperform” rating given on Tuesday, February 2 by BMO Capital Markets. On Tuesday, August 15 the stock rating was maintained by BMO Capital Markets with “Buy”.

Since May 17, 2017, it had 0 buys, and 1 insider sale for $303,211 activity. $303,211 worth of TJX Companies Inc (NYSE:TJX) was sold by Canestrari Kenneth. On Wednesday, May 17 Sherr Richard sold $89,110 worth of TJX Companies Inc (NYSE:TJX) or 1,179 shares.

The TJX Companies, Inc. is an off-price apparel and home fashions retailer in the United States and across the world. The company has market cap of $43.23 billion. The Firm operates through four divisions: Marmaxx, HomeGoods, TJX Canada and TJX International. It has a 18.36 P/E ratio. T.J.

Investors sentiment increased to 1.02 in 2017 Q2. Its up 0.04, from 0.98 in 2017Q1. It improved, as 64 investors sold TJX Companies Inc shares while 367 reduced holdings. 81 funds opened positions while 357 raised stakes. 550.70 million shares or 0.52% less from 553.56 million shares in 2017Q1 were reported. Baldwin Brothers Ma owns 3,700 shares for 0.04% of their portfolio. First Manhattan reported 15,287 shares. Deutsche Bancorp Ag invested in 3.90M shares or 0.2% of the stock. Research Management Company holds 0.05% or 1,900 shares. Thornburg Invest Mngmt Inc invested in 174,899 shares or 0.1% of the stock. Standard Life Limited holds 1.50 million shares. Victory Cap Mngmt stated it has 0.04% in TJX Companies Inc (NYSE:TJX). Salient Ltd Liability Corporation stated it has 0.12% in TJX Companies Inc (NYSE:TJX). Welch Group Inc Ltd Llc reported 0.04% of its portfolio in TJX Companies Inc (NYSE:TJX). The Rhode Island-based Amica Retiree Med Trust has invested 0.26% in TJX Companies Inc (NYSE:TJX). Adirondack Trust holds 285 shares or 0.02% of its portfolio. South State Corp reported 122,771 shares or 1.14% of all its holdings. First Citizens Savings Bank Trust reported 0.03% in TJX Companies Inc (NYSE:TJX). Cohen Lawrence B has 3.56% invested in TJX Companies Inc (NYSE:TJX) for 77,186 shares. 25,472 were accumulated by Meiji Yasuda Life Insur Com.

About 31,438 shares traded. TJX Companies Inc (NYSE:TJX) has declined 2.02% since November 15, 2016 and is downtrending. It has underperformed by 18.72% the S&P500.

Among 3 analysts covering Marrone Bio Innovations (NASDAQ:MBII), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Marrone Bio Innovations had 6 analyst reports since August 11, 2015 according to SRatingsIntel. Piper Jaffray maintained the stock with “Hold” rating in Friday, September 15 report. H.C. Wainwright maintained Marrone Bio Innovations Inc (NASDAQ:MBII) on Tuesday, August 15 with “Buy” rating. The firm has “Buy” rating given on Tuesday, August 11 by Zacks. The rating was maintained by Piper Jaffray on Friday, July 21 with “Hold”. The rating was maintained by Piper Jaffray with “Hold” on Monday, August 14. The rating was initiated by Rodman & Renshaw on Wednesday, March 16 with “Buy”.

Marrone Bio Innovations, Inc. offers bio pest management and plant health products. The company has market cap of $36.68 million. The Company’s bio products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It currently has negative earnings. It sells its products to crop protection market.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com